Frequency and Risk Factors of Acute Myeloid Leukemia
NCT05787951 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2023-03-28
Summary
1. to assess the frequency of acute myeloid leukemia at clinical Haematology unit of Assiute university hospital
2. to study correlations of known risk factors and if there are new risk factors participate in increasing frequency of acute myeloid leukemia
Conditions
- Myeloid Leukemia
Interventions
- DIAGNOSTIC_TEST
-
Bone marrow aspirite for diagnosis
Routine investigation of acute myeloid leukemia such as bone marrow aspirite for diagnosis ,cbc
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-05-01
- Primary Completion
- 2025-05-01
- Completion
- 2025-08-01
More Related Trials
-
D-index as a Predictor of Complication of Treatment of Patients With Acute Myeloid Leukemia
NCT06188182 ·Status: NOT_YET_RECRUITING
-
Analysis of T Cell Metabolism in Acute Myeloid Leukemia Patients
NCT04259372 ·Status: COMPLETED
-
Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition
NCT03284593 ·Status: ACTIVE_NOT_RECRUITING
-
CD155 Expression in Acute Myeloid Leukemia
NCT06369662 ·Status: COMPLETED
-
Relation of C-reactive Protein/ Albumin Ratio and Coagulation Profile in Acute Myeloid Leukemia Patients
NCT06714071 ·Status: NOT_YET_RECRUITING
-
Clinical Research for Azacitidine Combined With Low-dose Dasatinib in Maintenance Therapy of Acute Myeloid Leukemia
NCT05042531 ·Status: UNKNOWN ·Phase: NA
-
Immunophenotyping and Xist Gene in AML
NCT04288739 ·Status: UNKNOWN
-
The Prognostic Significance of Platelet to White Blood Cell Ratio (PWR) in Patients With Acute Myeloid Leukemia
NCT07115537 ·Status: NOT_YET_RECRUITING
-
Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
NCT01311258 ·Status: RECRUITING
-
Oral Arsenic Trioxide for NPM1-mutated AML
NCT04689815 ·Status: UNKNOWN ·Phase: PHASE2
-
Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia
NCT00003931 ·Status: COMPLETED
-
Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia
NCT00897182 ·Status: COMPLETED
-
Study of the Medullary Microenvironment in Acute Childhood Leukemia
NCT05792007 ·Status: RECRUITING ·Phase: NA
-
Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms - The Biology and Outcome (BiO)-Project
NCT01252485 ·Status: RECRUITING
-
Chronic Myelod Leukemia Registry at Asan Medical Center
NCT01761695 ·Status: TERMINATED
-
Phase II Trial of Alisertib With Induction Chemotherapy in High-risk AML
NCT02560025 ·Status: COMPLETED ·Phase: PHASE2
-
Screening of IDH1 and IDH2 Gene Mutations in Adult Acute Myeloid Leukemia for Possible Targeted Therapy
NCT03499912 ·Status: UNKNOWN
-
ObServatory Children Acute RElated Therapy Leukemia
NCT04450784 ·Status: UNKNOWN
-
Azacitidine Combined With Venetoclax and ATRA in Newly Diagnosed AML
NCT05654194 ·Status: UNKNOWN ·Phase: PHASE3
-
Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms
NCT04460950 ·Status: RECRUITING
-
Studying DNA in Blood and Bone Marrow Samples From Younger Patients With Acute Myeloid Leukemia
NCT01024127 ·Status: COMPLETED
-
Prognostic Values of Next Generation Sequencing (NGS) in Acute Myeloid Leukemia Patients With Allo-HSCT
NCT03715621 ·Status: UNKNOWN
-
Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia
NCT00002531 ·Status: UNKNOWN ·Phase: PHASE2
-
Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia
NCT01385150 ·Status: COMPLETED
-
Study of Management and Prognosis of Patients With Acute Myeloblastic Leukemia in Saint-Antoine Hospital
NCT05558943 ·Status: NOT_YET_RECRUITING